FDA Approves Aducanumab — A Controversial Drug For Alzheimer's
![FDA Approves Aducanumab — A Controversial Drug For Alzheimer's](https://www.podcastworld.io/podcast-images/short-wave-fs1irssd.webp)
For more of Jon's reporting, read "For Those Facing Alzheimer's, A Controversial Drug Offers Hope."
You can email Short Wave at ShortWave@NPR.org.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy